SanBio Co Diluted EPS
The Diluted Earnings per Share of SanBio Co (4592.T) as of Oct 15, 2026 is -49.23 JPY. In the previous year, Diluted Earnings per Share was -40.02 JPY — a change of 22.99% (lower).
Get this data via API
Financial Data API
Diluted EPS
-49.23JPY
YoY
22.99%
Last updated:
The SanBio Co Diluted EPS history
3 Years
10 Years
25 Years
Max
| YEAR | Diluted EPS | YoY |
|---|---|---|
| -49.23JPY | +22.99% | |
| -40.02JPY | +3.88% | |
| -38.53JPY | -54.66% | |
| -84.97JPY | +8.27% | |
| -78.48JPY | +20.05% | |
| -65.37JPY | -34.36% | |
| -99.60JPY | +76.59% | |
| -56.40JPY | -28.82% | |
| -79.23JPY | +97.62% | |
| -40.09JPY | +83.64% | |
| -21.83JPY | -156.12% | |
| 38.90JPY | -615.15% | |
| -7.55JPY | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
SanBio Co Stock analysis
Frequently Asked Questions about SanBio Co stock
Diluted Earnings per Share of SanBio Co is -49.23 JPY in 2026.
Diluted Earnings per Share of SanBio Co changed from -40.02 JPY to -49.23 JPY, representing a 22.99% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Diluted Earnings per Share SanBio Co since 2006 – with annual values, charts, and detailed analysis.
Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — SanBio Co
All Key Metrics — SanBio Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth